شرح
CD55, also well known as decay-accelerating factor (DAF), is a member of the RCA (regulators of complement activation) family characterized by four to 30 SCRs (short consensus repeats) in their plasma-exposed regions. It is a major regulator of the alternative and classical pathways of complement activation and is expressed on all serum-exposed cells. CD55 is physiologically acting as an inhibitor of the complement system, but is also broadly expressed in malignant tumours.
Specifications
|
Cat.No. |
96574ES60 / 96574ES76 |
|
Size |
100 μg / 500 μg |
Components
|
Name |
96574ES60 |
96574ES76 |
|
Recombinant Human CD55/DAF Protein,hFc Tag |
100 μg |
500 μg |
Performance parameters
|
Synonyms |
CD55,CD55 molecule,CD55,CR,DAF |
|
Species |
Human |
|
Expression Sequence |
Asp35-Ser353,with C-terminal Fc |
|
Accession |
P08174-4 |
|
Tag |
C-hFc Tag |
|
Expression System |
HEK293 |
|
Molecular Weight |
72-90 kDa (Reducing) |
|
Purity |
> 95% as determined by SDS-PAGE. |
|
Endotoxin |
<0.1 EU/μg |
|
Formulation |
PBS, pH7.4. |
|
Appearance |
Lyophilized Powder |
|
Reconstitution |
Reconstitute at 0.1-1 mg/mL according to the size in ultrapure water after rapid centrifugation. |
Storage
Store at -25°C to -15°C for 1 year upon receipt; after reconstitution under aseptic conditions, the product is stable for 7 days at 2°C to 8°C or for 3 months at -85°C to -65°C.
Notes
1. This product is for research use only.
2. Please operate with lab coats and disposable gloves, for your safety.
Documents:
Manual
Payment & Security
اطلاعات پرداخت شما با اطمینان پردازش می شود. ما جزئیات کارت اعتباری را ذخیره نمی کنیم و به اطلاعات کارت اعتباری شما دسترسی نداریم.
You may also like
Inquiry
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.